Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients (NCT06744712)
🩺 Plain-English Summary (8th-Grade Level)
Pharmacogenomic (PGx) testing involves analyzing variants of genes associated with drug metabolism, transport and medication targets. PGx testing uses an individual's genetic factors, such as single nucleotide polymorphisms (SNPs), to personalize therapy or dose a selection of medications. PGx testing has traditionally been used to test single genes, but there are now platforms allowing a panel of genes to be tested at once. To date there has not been a comprehensive screening of pediatric oncology patients to determine the prevalence of genetic variants that may affect anticancer therapy and supportive care medications. This study would allow us to summarize the frequency of clinically relevant gene-drug interactions and actionable genetic polymorphisms in pediatric oncology patients.
Who can join: Review the eligibility criteria below.
Location: Levine Childrens Hospital Pediatric Cancer and Blood Disorders — Charlotte, North Carolina
Age range: Not specified to 26 Years
🧪 Interventions in This Study
- Pharmacogenomic Testing (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Levine Childrens Hospital Pediatric Cancer and Blood Disorders — Charlotte, North Carolina
📞 Contact the Study Coordinator
Phone: (980) 349-6887
Email: megan.lattanze@advocatehealth.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pediatric Cancer
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group — Arcadia, California
- Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors — Houston, Texas
- Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images — Memphis, Tennessee
- ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer — Hartford, Connecticut
- Durvalumab and Tremelimumab for Pediatric Malignancies — Baltimore, Maryland
- Medically Tailored Meals for Kids — Chapel Hill, North Carolina
Explore by condition: All Pediatric Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.